Acid Control 150 Side Effects

Generic name: ranitidine

Medically reviewed by Drugs.com. Last updated on Mar 27, 2024.

Note: This document provides detailed information about Acid Control 150 Side Effects associated with ranitidine. Some dosage forms listed on this page may not apply specifically to the brand name Acid Control 150.

Applies to ranitidine: compounding powder, injectable solution, intravenous solution, oral capsule, oral granule effervescent, oral syrup, oral tablet, oral tablet effervescent.

Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.

Stop using ranitidine (the active ingredient contained in Acid Control 150) and call your doctor at once if you have:

• stomach pain, loss of appetite;

• dark urine, jaundice (yellowing of the skin or eyes);

• fever, chills, cough with mucus, chest pain, feeling short of breath;

• fast or slow heart rate;

• easy bruising or bleeding; or

• problems with your skin or hair.

Common side effects may include:

• nausea, vomiting, stomach pain; or

• diarrhea, constipation.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.

See also:

For healthcare professionals

Applies to ranitidine: compounding powder, injectable solution, intravenous solution, oral capsule, oral granule effervescent, oral syrup, oral tablet, oral tablet effervescent.

General adverse events

The most commonly reported side effect for IM administration was injection site pain, and the most commonly reported side effects with IV administration were localized pain and burning.^[Ref]

Gastrointestinal

• Uncommon (0.1% to 1%): Abdominal discomfort/pain, constipation, nausea, vomiting
• Very rare (less than 0.01%): Acute pancreatitis, diarrhea^[Ref]

Abdominal pain, constipation, and nausea tended to improve with continued treatment.^[Ref]

Cardiovascular

• Rare (0.01% to 0.1%): Hypotension, chest pain, arrhythmia, bradycardia, atrioventricular block, tachycardia, premature ventricular beats
• Very rare (less than 0.01%): Asystole, vasculitis^[Ref]

Bradycardia, atrioventricular block, tachycardia, and asystole have occurred in H2 receptor antagonists.^[Ref]

Psychiatric

• Rare (0.01% to 0.1%): Insomnia, reversible mental confusion, agitation, depression, hallucinations
• Frequency not reported: Loss of libido^[Ref]

Nervous system

• Rare (0.01% to 0.1%): Dizziness, somnolence, vertigo, reversible involuntary movement disorders
• Very rare (less than 0.01%): Headache/severe headache^[Ref]

Headache may be related to administration of treatment.^[Ref]

Dermatologic

• Rare (0.01% to 0.1%): Urticaria, angioneurotic edema, skin rash
• Very rare (less than 0.01%): Erythema multiforme, alopecia^[Ref]

Musculoskeletal

• Very rare (less than 0.01%): Musculoskeletal symptoms, arthralgia, myalgia^[Ref]

Hepatic

• Rare (0.01% to 0.1%): Transient and reversible changes in liver function tests, increased ALT levels
• Very rare (less than 0.01%): Hepatocellular/hepatocanalicular/mixed hepatitis with/without jaundice^[Ref]

Hepatitis with/without jaundice were usually reversible.

ALT levels increased to at least 2 times the pretreatment levels in patients receiving high IV doses for at least 5 days.^[Ref]

Other

• Rare (0.01% to 0.1%): Fever, malaise
• Frequency not reported: Death^[Ref]

Hypersensitivity

• Rare (0.01% to 0.1%): Hypersensitivity reactions
• Very rare (less than 0.01%): Anaphylactic shock/anaphylaxis^[Ref]

Anaphylactic shock occurred after administration of a single dose.^[Ref]

Renal

• Rare (0.01% to 0.1%): Elevation in serum creatinine
• Very rare (less than 0.01%): Acute interstitial nephritis^[Ref]

Elevation in serum creatinine was usually slight, and typically normalized with continued treatment.^[Ref]

Respiratory

• Rare (0.01% to 0.1%): Bronchospasm
• Frequency not reported: Dyspnea, pneumonia^[Ref]

Ocular

• Rare (0.01% to 0.1%): Reversible blurred vision^[Ref]

Hematologic

• Very rare (less than 0.01%): Blood count changes, leukopenia, thrombocytopenia, granulocytopenia, agranulocytosis, pancytopenia, marrow hypoplasia/aplasia
• Frequency not reported: Aplastic anemia, immune hemolytic anemia/acquired immune hemolytic anemia, eosinophilia^[Ref]

Leukopenia, granulocytopenia, and thrombocytopenia were usually reversible.^[Ref]

Genitourinary

• Very rare (less than 0.01%): Reversible impotence, breast symptoms/conditions, galactorrhea^[Ref]

Endocrine

• Very rare (less than 0.01%): Gynecomastia^[Ref]

Metabolic

• Postmarketing reports: Acute porphyria^[Ref]

Local

• Frequency not reported: Injection site pain, transient localized burning or itching^[Ref]

Further information

Acid Control 150 side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer